IL-1β neutralization promotes intratumoral CD8+ T cell infiltration and function and sensitizes PDA to immunotherapy, confirming that the effects of tumor cell-derived IL-1β are NLRP3-dependent and identifying a tumor-supportive role for NLRP3 in PC [105]. The gene discussed is NLRP3; the disease is neoplasm.